News & Podcast
Stay up to date with the latest stories, deep-dives and interviews from the Munich startup ecosystem. From funding deals to founder portraits and tech trends.

4C Accelerator sucht Medtech-Startups für Batch #12
The 4C Accelerator is launching its twelfth round: Until August 3, 2026, medtech startups can apply for the funding program. Participants can expect a combination of workshops and individual coaching with a focus on regulatory requirements and market entry.

Sedivention secures €2.9 million in seed funding
The medtech startup Sedivention has completed a €2.9 million seed funding round led by bmp Ventures with the IBG Fonds. With the capital, the company plans to further develop a minimally invasive outpatient therapy for obesity and generate initial clinical data for its planned market entry.

Pre-seed funding for Onyx Biotech
The Munich-based startup Onyx Biotech has completed a pre-seed funding round with the Life Science Valley Growth Fund, Freiraum Ventures, and several business angels. Founded in 2024, the company develops simulation-based digital twins that are designed to save up to 96 percent of laboratory experiments in the development of modern biologics.

Rnatics: Hope in pulmonary fibrosis
Rnatics is developing RCS-21, a novel inhalable drug against lung inflammation and idiopathic pulmonary fibrosis. The startup was founded in 2021 as a spin-off from TUM by Stefan Engelhardt together with Thomas Frischmuth and Klaus Rabe. After promising research and ongoing clinical studies, the team aims to reach the next milestones and create new therapy options for patients. Clinical lead and pharmacist with a PhD, Christina Beck, explains the details about the founding and mission to us.

XO Life secures 4 million euros
XO Life was founded in 2021 and develops a globally unique meta-platform from Munich. It is designed to support patients from diagnosis through the start of therapy to digital support during the course of treatment. Now the Munich-based digital health startup is securing new capital.

Tubulis acquired by American pharma giant
Munich-based biotech unicorn Tubulis is being acquired by US company Gilead for a multibillion-euro amount.

All eyes on Custom Surgical: The end of analog ophthalmology?
Munich startup Custom Surgical has completed a pre-series A funding round, is moving into new offices at the Munich Technology Center, and plans to double its team. The company combines hardware, cloud platform, and AI to digitalize and scale ophthalmological diagnostics.

SAP invests in Avelios Medical
Munich-based software provider Avelios Medical receives a strategic investment from SAP. Together, the partners are developing a new digital platform for hospitals, responding to the planned replacement of central IT systems in the clinical market.

Noxon flexes its muscles
Medtech startup Noxon has completed seed funding of several million euros. Goal: to certify the muscle-computer interface for rehabilitation and neurology.

Custom Surgical raises funding for digitalization of ophthalmology
Munich-based medtech startup Custom Surgical receives 3.5 million euros from Ventech, Zeiss, and other investors. With the pre-Series A round, the company is advancing the digitalization of workflows in ophthalmology and its international expansion.

Certhub raises €6.2 million
The Munich-based medtech startup Certhub secures fresh capital for its AI-powered compliance platform. The funding is intended to drive scaling across Europe and open up new markets.

4C Accelerator sucht Medtech-Startups
The 4C Accelerator starts batch 11. Startups in medical devices, software as a medical device, and in vitro diagnostics can apply until February 10, 2026 for the free online program and become investor-ready faster.